BBIO logo

BridgeBio Pharma (BBIO)

Profile

Full Name

BridgeBio Pharma, Inc.

Ticker Symbol

BBIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 27, 2019

Indexes

Not included

Website

http://bridgebio.com

Employees

725

Key Details

Price

$44.86(-0.58%)

Market cap

$8.52B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$221.90M(+2285.27% YoY)

Annual EPS

-$2.88(+27.09% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $44.86
    BBIO price is $44.86

    30-Day Relative Volume

    2.94
    BBIO 30-day relative volume is 2.94

    Price Performance

    Price Most recent change

    -0.58%
    BBIO price was down -0.58% on Jun 27, 2025

    Price YTD change

    +63.48%
    BBIO price is up +63.48% since January 1st

    Price 1-year change

    +78.02%
    BBIO price is up +78.02% year-on-year

    Price 3-year change

    +380.3%
    BBIO price is up +380.3% over the past 3 years

    Price Range

    Price All-time high

    $73.50
    BBIO price is currently -38.97% below its historical high of $73.50

    Price 3-year low

    $6.55
    BBIO price is currently +584.89% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.52B
    BBIO market capitalization is $8.52 billion

    Market cap 3-year change

    +517.49%
    BBIO market capitalization is up +517.49% over the past 3 years

    Market cap All-time high

    $10.77B
    BBIO market capitalization is currently -20.89% below its historical high of $10.77 billion

    Market cap sector rank

    91.57%
    BBIO market capitalization is higher than 91.57% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.47%
    BBIO shares outstanding is up +1.47% year-on-year

    Shares Outstanding 3-Year Change

    +28.56%
    BBIO shares outstanding is up +28.56% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.00
    BBIO beta is 1.00

    200-day SMA

    $31.41
    BBIO price is currently +42.82% above its 200-day simple moving average

    50-day SMA

    $36.99
    BBIO price is currently +21.26% above its 50-day simple moving average

    RSI

    75.66
    BBIO 14-day relative strength index is 75.66

    Volume

    2.94
    BBIO 30-day relative volume is 2.94

    ATR

    $1.51
    BBIO average true range is $1.51

    10-day Historical Volatility

    39.09%
    BBIO 10-day historical volatility is 39.09%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $221.90M
    BBIO annual revenue is $221.90 million

    Revenue Analysts estimate

    $436.25M
    BBIO annual revenue is currently -49.13% lower than the consensus analysts' forecast

    Revenue 1-year change

    +2285.27%
    BBIO annual revenue is up +2285.27% year-on-year

    Revenue Sector rank

    65.5%
    BBIO annual revenue is higher than 65.5% of companies in Healthcare sector

    EPS

    EPS

    -$2.88
    BBIO annual earnings per share is -$2.88

    EPS Analysts estimate

    -$2.34
    BBIO annual earnings per share is currently +23.26% higher than the consensus analysts' forecast

    EPS 1-year change

    +27.09%
    BBIO annual earnings per share is up +27.09% year-on-year

    EPS Sector rank

    31.36%
    BBIO annual earnings per share is higher than 31.36% of companies in Healthcare sector

    Profit

    Gross profit

    $218.02M
    BBIO annual gross profit is $218.02 million

    Gross margin

    98.25%
    BBIO annual gross profit margin is 98.25%

    Operating profit

    -$577.37M
    BBIO annual operating income is -$577.37 million

    Operating margin

    -260.19%
    BBIO annual operating profit margin is -260.19%

    Net income

    -$535.76M
    BBIO annual net profit is -$535.76 million

    Net margin

    -241.44%
    BBIO annual net profit margin is -241.44%

    Expenses

    Total expenses

    $799.27M
    BBIO annual total expenses is $799.27 million

    Operating expenses

    $795.39M
    BBIO annual total operating expenses is $795.39 million

    Cost of goods sold

    $3.88M
    BBIO annual cost of goods sold is $3.88 million

    Selling, general & administrative expenses

    $288.93M
    BBIO annual SGA is $288.93 million

    Depreciation and amortization

    $6.08M
    BBIO annual depreciation & amortization is $6.08 million

    Interest expense

    $99.29M
    BBIO annual interest expense is $99.29 million

    Income tax

    $1.15M
    BBIO annual income tax is $1.15 million

    EBIT & EBITDA

    EBIT

    -$442.90M
    BBIO annual earnings before interest & taxes is -$442.90 million

    EBITDA

    -$436.83M
    BBIO annual EBITDA is -$436.83 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $919.34M
    BBIO annual total assets is $919.34 million

    Non current assets

    $198.65M
    BBIO annual long term assets is $198.65 million

    Current assets

    $720.69M
    BBIO annual total current assets is $720.69 million

    Cash and cash equivalents

    $681.10M
    BBIO annual cash & cash equivalents is $681.10 million

    Accounts receivable

    $4.72M
    BBIO annual accounts receivable is $4.72 million

    Inventory

    -
    BBIO annual inventory value is unknown

    Liabilities

    Total liabilities

    $2.38B
    BBIO annual total liabilities is $2.38 billion

    Long term liabilities

    $2.22B
    BBIO annual total long term liabilities is $2.22 billion

    Current liabilities

    $154.40M
    BBIO annual total current liabilities is $154.40 million

    Accounts payable

    $9.62M
    BBIO annual accounts payable is $9.62 million

    Debt

    Total debt

    $1.73B
    BBIO annual total debt is $1.73 billion

    Total debt 1-year change

    -0.53%
    BBIO annual total debt is down -0.53% year-on-year

    Long term debt

    $1.73B
    BBIO annual long term debt is $1.73 billion

    Short term debt

    $4.51M
    BBIO annual short term debt is $4.51 million

    Equity & Capital

    Shareholders equity

    -$1.47B
    BBIO annual stockholders equity is -$1.47 billion

    Book value

    -$1.47B
    BBIO annual book value is -$1.47 billion

    Retained earnings

    -$3.10B
    BBIO annual retained earnings is -$3.10 billion

    Working capital

    $566.29M
    BBIO annual working capital is $566.29 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$520.73M
    BBIO annual cash flow from operations is -$520.73 million

    Cash from operations 1-year change

    +1.33%
    BBIO annual cash flow from operations is up +1.33% year-on-year

    Cash from investing

    $60.78M
    BBIO annual cash flow from investing activities is $60.78 million

    Cash from investing 1-year change

    +12.49%
    BBIO annual cash flow from investing activities is up +12.49% year-on-year

    Cash from financing

    $748.46M
    BBIO annual cash flow from financing activities is $748.46 million

    Cash from financing 1-year change

    +65.76%
    BBIO annual cash flow from financing activities is up +65.76% year-on-year

    CAPEX

    CAPEX

    $8.91M
    BBIO annual capital expenditures is $8.91 million

    CAPEX 1-year change

    +582.08%
    BBIO annual capital expenditures is up +582.08% year-on-year

    Free Cash Flow

    Free cash flow

    -$529.63M
    BBIO annual free cash flow is -$529.63 million

    Free cash flow 1-year change

    -0.11%
    BBIO annual free cash flow is down -0.11% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    98.25%
    BBIO annual gross profit margin is 98.25%

    Operating margin

    -260.19%
    BBIO annual operating profit margin is -260.19%

    Net margin

    -241.44%
    BBIO annual net profit margin is -241.44%

    ROA & ROE

    ROA

    -73.11%
    BBIO annual return on assets is -73.11%

    ROE

    36.50%
    BBIO annual return on equity is 36.50%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BBIO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BBIO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -5.17
    BBIO price to book ratio is -5.17

    PB ratio Sector rank

    5.16%
    BBIO price to book ratio is higher than 5.16% of companies in Healthcare sector

    PS Ratio

    PS ratio

    66.85
    BBIO price to sales ratio is 66.85

    PS ratio Sector rank

    92.72%
    BBIO price to sales ratio is higher than 92.72% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $9.84B
    BBIO enterprise value is $9.84 billion

    Enterprise value Sector rank

    91.43%
    BBIO enterprise value is higher than 91.43% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -17.82
    BBIO EV/EBITDA is -17.82

    EV/EBITDA Sector rank

    8.01%
    BBIO EV/EBITDA is higher than 8.01% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.67
    BBIO annual current ratio is 4.67

    Quick ratio

    -
    BBIO annual quick ratio value is unknown

    Leverage

    Debt to equity

    -1.17
    BBIO annual debt to equity ratio is -1.17

    Interest coverage ratio

    -4.46
    BBIO annual interest coverage ratio is -4.46

    Risk & Stability

    Piotroski F-Score

    1
    BBIO piotroski f-score is 1

    Altman Z-Score

    -3.17
    BBIO altman z-score is -3.17

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 Wolfe Research
    Outperform
    Jun 9, 25 HC Wainwright & Co.
    Buy
    Apr 30, 25 UBS
    Buy
    Apr 30, 25 Scotiabank
    Sector Outperform
    Apr 30, 25 Piper Sandler
    Overweight
    Apr 15, 25 HC Wainwright & Co.
    Buy
    Mar 31, 25 Redburn Atlantic
    Buy
    Mar 24, 25 JP Morgan
    Overweight
    Feb 21, 25 Scotiabank
    Sector Outperform
    Feb 21, 25 Citigroup
    Buy

    Institutional Ownership

    Screeners with BBIO included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for BridgeBio Pharma?
    • Does BridgeBio Pharma pay dividends?
    • What sector is BridgeBio Pharma in?
    • What industry is BridgeBio Pharma in?
    • What country is BridgeBio Pharma based in?
    • When did BridgeBio Pharma go public?
    • Is BridgeBio Pharma in the S&P 500?
    • Is BridgeBio Pharma in the NASDAQ 100?
    • Is BridgeBio Pharma in the Dow Jones?
    • When was BridgeBio Pharma's last earnings report?
    • When does BridgeBio Pharma report earnings?
    • Should I buy BridgeBio Pharma stock now?

    What is the ticker symbol for BridgeBio Pharma?

    The ticker symbol for BridgeBio Pharma is NASDAQ:BBIO

    Does BridgeBio Pharma pay dividends?

    No, BridgeBio Pharma does not pay dividends

    What sector is BridgeBio Pharma in?

    BridgeBio Pharma is in the Healthcare sector

    What industry is BridgeBio Pharma in?

    BridgeBio Pharma is in the Biotechnology industry

    What country is BridgeBio Pharma based in?

    BridgeBio Pharma is headquartered in United States

    When did BridgeBio Pharma go public?

    BridgeBio Pharma's initial public offering (IPO) was on June 27, 2019

    Is BridgeBio Pharma in the S&P 500?

    No, BridgeBio Pharma is not included in the S&P 500 index

    Is BridgeBio Pharma in the NASDAQ 100?

    No, BridgeBio Pharma is not included in the NASDAQ 100 index

    Is BridgeBio Pharma in the Dow Jones?

    No, BridgeBio Pharma is not included in the Dow Jones index

    When was BridgeBio Pharma's last earnings report?

    BridgeBio Pharma's most recent earnings report was on Apr 29, 2025

    When does BridgeBio Pharma report earnings?

    The next expected earnings date for BridgeBio Pharma is Aug 1, 2025

    Should I buy BridgeBio Pharma stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page